ACUTE MYELOMONOCYTIC LEUKEMIA WITH INV(16)(P13Q22) COMPLICATING PHILADELPHIA-CHROMOSOME POSITIVE CHRONIC MYELOID-LEUKEMIA

被引:34
作者
HEIM, S
CHRISTENSEN, BE
FIORETOS, T
SORENSEN, AG
PEDERSEN, NT
机构
[1] ODENSE UNIV,DEPT MED GENET,DK-5230 ODENSE,DENMARK
[2] ODENSE UNIV HOSP,DEPT HEMATOL,DK-5000 ODENSE,DENMARK
[3] ODENSE UNIV HOSP,DEPT PATHOL,DK-5000 ODENSE,DENMARK
关键词
D O I
10.1016/0165-4608(92)90154-Z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The reciprocal translocation (9;22)(q34;q11) is highly characteristic of chronic myeloid leukemia (CML) and the pericentric inversion inv(16)(p13q22) is almost only found in acute nonlymphocytic leukemia of the myelomonocytic subtype (ANLL M4). Only twice before have an inv(16) and a t(9;22) been found in the same cells, and both times the patients seemed to have de novo ANLL M4. We describe the case of a 21-year-old man who in July 1986 presented with a clinically and hematologically classic chronic phase CML. Treatment with busulfan led to no improvement; instead in September 1986 he developed blast crisis with ANL M4Eo morphology. He was now cytogenetically examined and the karotype 45,X,- Y,t(9;22)(q34;q11),inv(16)(p13q22) was found. Southern blot analysis of the bone marrow DNA sampled at this time revealed a standard rearrangement in the 3' end of the M-bcr. Intensive cytostatic treatment caused cytopenia followed by complete hematologic, clinical, and cytogenetic reversal to chronic phase CML, so that in January 1987 the bone marrow karyotype was 46,XY,t(9;22)(q34;q11). Persistent splenomegaly was treated with splenectomy, and a chloroma of the skin was removed by irradiation. In March 1987 he received an allogeneic bone marrow transplant. Since then his only medical problem has been mild graft-versus-host disease; he is well and is working full time as a blacksmith.
引用
收藏
页码:35 / 38
页数:4
相关论文
共 28 条
[1]   TERMINAL-PHASE CHRONIC MYELOGENOUS LEUKEMIA - APPROACHES TO TREATMENT [J].
ALLEN, SL ;
COLEMAN, M .
CANCER INVESTIGATION, 1985, 3 (05) :491-503
[2]   THE CLINICAL-SIGNIFICANCE OF KARYOTYPE IN ACUTE MYELOGENOUS LEUKEMIA [J].
ARTHUR, DC ;
BERGER, R ;
GOLOMB, HM ;
SWANSBURY, GJ ;
REEVES, BR ;
ALIMENA, G ;
VANDENBERGHE, H ;
BLOOMFIELD, CD ;
DELACHAPELLE, A ;
DEWALD, GW ;
GARSON, OM ;
HAGEMEIJER, A ;
KANEKO, Y ;
MITELMAN, F ;
PIERRE, RV ;
RUUTU, T ;
SAKURAI, M ;
LAWLER, SD ;
ROWLEY, JD .
CANCER GENETICS AND CYTOGENETICS, 1989, 40 (02) :203-216
[3]  
ARTHUR DC, 1983, BLOOD, V61, P994
[4]  
BENNETT JM, 1985, ANN INTERN MED, V103, P626
[5]   T(15 - 17) IN A PROMYELOCYTIC FORM OF CHRONIC MYELOID-LEUKEMIA BLASTIC CRISIS [J].
BERGER, R ;
BERNHEIM, A ;
DANIEL, MT ;
FLANDRIN, G .
CANCER GENETICS AND CYTOGENETICS, 1983, 8 (02) :149-152
[6]  
BERNARD P, 1989, LEUKEMIA, V3, P740
[7]  
BERNSTEIN R, 1988, SEMIN HEMATOL, V25, P20
[8]   ASSOCIATIONS BETWEEN MORPHOLOGY, KARYOTYPE, AND CLINICAL-FEATURES IN MYELOID LEUKEMIAS [J].
BITTER, MA ;
LEBEAU, MM ;
ROWLEY, JD ;
LARSON, RA ;
GOLOMB, HM ;
VARDIMAN, JW .
HUMAN PATHOLOGY, 1987, 18 (03) :211-225
[9]  
BLOOMFIELD CD, 1987, SEMIN ONCOL, V14, P372
[10]  
CAMPBELL LJ, 1909, GENE CHROMOSOME CANC, V3, P55